In Thursday’s Wall Street session, Adma Biologics Inc (NASDAQ:ADMA) shares traded at $21.20, down -10.21% from the previous session.
ADMA stock price is now 6.28% away from the 50-day moving average and 16.99% away from the 200-day moving average. The market capitalization of the company currently stands at $5.06B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
On October 13, 2022, Mizuho recently initiated its ‘Buy’ rating on the stock quoting a target price of $5, while ‘Raymond James’ rates the stock as ‘Strong Buy’
In other news, Grossman Adam S, President and CEO sold 21,000 shares of the company’s stock on Apr 15 ’25. The stock was sold for $450,660 at an average price of $21.46. Upon completion of the transaction, the President and CEO now directly owns 2,055,850 shares in the company, valued at $43.58 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 19 ’25, President and CEO Grossman Adam S sold 21,000 shares of the business’s stock. A total of $397,320 was realized by selling the stock at an average price of $18.92. This leaves the insider owning 2,061,850 shares of the company worth $43.71 million. A total of 3.49% of the company’s stock is owned by insiders.
During the past 12 months, Adma Biologics Inc has had a low of $6.72 and a high of $25.67. As of last week, the company has a debt-to-equity ratio of 0.22, a current ratio of 6.58, and a quick ratio of 3.36.
The net profit margin was 45.01% and return on equity was 78.45% for ADMA. The company reported revenue of $114.8 million for the quarter, compared to $81.88 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 40.22 percent.
